Q: Pat: I am looking for your advice on the iShares S&P/TSX Composite High Dividend Index ETF. Thanks.

A: The iShares S&P/TSX Composite High Dividend Index ETF, $24.44, symbol XEI on Toronto (Units outstanding: 58.7 million; Market cap: $1.4 billion; www.blackrock.com/ca), aims to track the S&P/TSX Composite High Dividend Index, which effectively holds the 75 highest-yielding Canadian stocks.

The index is market-capitalization weighted, with… Read More

The biotech industry is exciting but risky

Biotechnology is a science-driven industry that uses living organisms and molecular biology to produce healthcare-related products. Biotechnology is best known for its role in medicine and pharmaceuticals, but the science is also applied in other areas such as genomics, food production, and the production of… Read More

Two new ETFs for Canadian investors

Invesco is one of the top global fund managers and it recently made another product available to Canadian investors. Horizons has also become one of the largest Canadian ETF managers by launching creative new products.
INVESCO MORNINGSTAR GLOBAL ENERGY TRANSITION ETF $19.43 (Toronto symbol IGET) invests globally in… Read More

United States: Unparalleled long-term prospects

The United States has been the world’s leading economy for many decades—and we think U.S. companies will continue to offer ETF investors unparalleled opportunities.
Here is an ETF that provides exposure to the top U.S. stocks.
VANGUARD TOTAL STOCK MARKET ETF $82.24 (Toronto symbol VUN; TSI Network ETF… Read More

Fossil fuels will be around for a while yet

Oil and gas prices have pulled back lately, but still remain high. Meanwhile, demand should remain elevated for several years to come as the world continues to rely on fossil fuels even as it shifts to more-sustainable renewable energy sources.
Here are three ETFs that focus… Read More

Pass on this ETF: Ark Genomic Revolution ETF

ARK GENOMIC REVOLUTION ETF $31.33 (CBOE symbol ARKG) invests globally in companies it expects to benefit from the development of products and services meant to improve the quality of life. Those firms are involved in molecular diagnostics, gene therapy, targeted therapeutics, agricultural biology, and stem cells.
The ETF launched in… Read More

Use these to boost your biotech exposure

Biotechnology companies have been at the forefront of some of the most exciting developments in healthcare over the past two decades—and there are more developments in the pipeline. However, the high cost of product development, long lead times for product testing and regulatory approvals, and… Read More